Sign in to view content

Brolucizumab: Will it Make a Differance

Andrew P. Schachat, MD

Video
Published 2018

Related

Episode 29: Anti-VEGF Levels in Breast Milk after Intravitreal Injections- Drs. Muni and Juncal
Keyvan Koushan, MD, FRCSC
Member Podcasts
Anti-VEGF Injection Prior Authorization Impacts on Retina Practices
Sabin Dang, MD
Updates from the Field
2022
Phase IIIb TALON study of brolucizumab versus aflibercept in a matched treat-and-extend regimen to treat neovascular AMD: 32-week primary outcomes
Carl D. Regillo, MD
Annual Meeting Talks
2022

Category: AMD-Neovascular

See more